Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.13B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 3 |
Apple
AAPL
|
+$836M |
| 4 |
Alibaba
BABA
|
+$807M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$566M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$429M |
| 2 |
Boeing
BA
|
+$402M |
| 3 |
Coty
COTY
|
+$284M |
| 4 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$104M |
| 5 |
Qualcomm
QCOM
|
+$102M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.44% |
| 2 | Consumer Discretionary | 1.83% |
| 3 | Communication Services | 1.72% |
| 4 | Financials | 1.35% |
| 5 | Healthcare | 1.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGEN
1676
CALL
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.4M | ﹤0.01% |
178,900
+10,100
| +6% | +$707K |
|
1677
CALL
Acadia Pharmaceuticals
ACAD
$5.11B
| $12.4M | ﹤0.01% |
463,200
-112,500
| -20% | -$2.87M |
|
1678
PUT
Tenet Healthcare
THC
$22.3B
| $12.3M | ﹤0.01% |
596,300
+107,800
| +22% | +$2.48M |
|
1679
Steel Dynamics
STLD
$33.8B
| $12.3M | ﹤0.01% |
+407,347
| New | +$12.5M |
|
1680
PUT
Johnson Controls International
JCI
$87.4B
| $12.3M | ﹤0.01% |
297,500
+121,000
| +69% | +$4.65M |
|
1681
Ionis Pharmaceuticals
IONS
$10.5B
| $12.3M | ﹤0.01% |
191,116
+174,810
| +1,072% | +$12.4M |
|
1682
CALL
Polaris
PII
$3.6B
| $12.3M | ﹤0.01% |
134,600
+83,700
| +164% | +$7.62M |
|
1683
CALL
ArcelorMittal
MT
$56.2B
| $12.3M | ﹤0.01% |
679,600
+349,900
| +106% | +$6.6M |
|
1684
CALL
F5
FFIV
$22.5B
| $12.2M | ﹤0.01% |
84,100
-48,400
| -37% | -$7.25M |
|
1685
PUT
Truist Financial
TFC
$62B
| $12.2M | ﹤0.01% |
249,000
-80,400
| -24% | -$3.94M |
|
1686
PUT
Signet Jewelers
SIG
$3.25B
| $12.2M | ﹤0.01% |
684,000
-247,700
| -27% | -$5.32M |
|
|
GWR
1687
PUT
DELISTED
Genesee & Wyoming Inc.
GWR
| $12.2M | ﹤0.01% |
122,200
+59,800
| +96% | +$5.45M |
|
1688
PUT
CRISPR Therapeutics
CRSP
$5.74B
| $12.2M | ﹤0.01% |
259,200
-116,800
| -31% | -$4.67M |
|
|
LTRPA
1689
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $12.2M | ﹤0.01% |
983,394
+71,245
| +8% | +$934K |
|
1690
AGNC Investment
AGNC
$12.9B
| $12.2M | ﹤0.01% |
+723,873
| New | +$12.6M |
|
1691
CALL
Labcorp
LH
$27.3B
| $12.2M | ﹤0.01% |
81,829
-51,216
| -38% | -$7.15M |
|
1692
CALL
Teleflex
TFX
$5.92B
| $12.2M | ﹤0.01% |
36,700
-7,900
| -18% | -$2.38M |
|
|
GAP
1693
CALL
The Gap Inc
GAP
$7.61B
| $12.1M | ﹤0.01% |
675,400
+104,300
| +18% | +$2.34M |
|
|
DCH
1694
PUT
Dauch Corp
DCH
$1.51B
| $12.1M | ﹤0.01% |
950,400
-749,300
| -44% | -$9.75M |
|
1695
PUT
GoPro
GPRO
$108M
| $12.1M | ﹤0.01% |
2,219,600
+414,400
| +23% | +$2.63M |
|
1696
CALL
Murphy USA
MUSA
$9.99B
| $12.1M | ﹤0.01% |
144,200
+71,100
| +97% | +$5.95M |
|
|
1697
CALL
GoPro
GPRO
$108M
| $12.1M | ﹤0.01% |
2,218,700
-52,500
| -2% | -$334K |
|
1698
LendingTree
TREE
$422M
| $12.1M | ﹤0.01% |
+28,818
| New | +$11M |
|
|
HUYA
1699
PUT
Huya Inc
HUYA
$491M
| $12.1M | ﹤0.01% |
489,200
+90,600
| +23% | +$2.08M |
|
1700
BioMarin Pharmaceuticals
BMRN
$12.8B
| $12.1M | ﹤0.01% |
+141,098
| New | +$12.1M |
|
Similar funds
Jeff Yass's Q2 2019 Portfolio in Review
As of Q2 2019, Jeff Yass held 11,369 positions worth $275B, up 13% from $243B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass deployed $25.4B of net new capital in Q2 2019, opening 2,651 new positions and adding to 3,766 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, up from 1.4% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Walt Disney, an estimated $429M trimmed.
- Jeff Yass's largest Q2 2019 buy was State Street SPDR S&P 500 ETF Trust: 14,345,542 shares worth $4.2B.
- Jeff Yass added most to Alphabet (Google) Class A in Q2 2019, an estimated $1.18B increase.
- Jeff Yass's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $429M.
- Jeff Yass fully exited Goldcorp Inc in Q2 2019, selling an estimated $26.4M.
- Jeff Yass's ten largest holdings make up 24% of its $275B portfolio in Q2 2019.
- Jeff Yass opened 2,651 new positions and closed 1,221 in Q2 2019.
- Jeff Yass's portfolio value rose 13% quarter-over-quarter to $275B.
Based on Susquehanna International Group's 13F filing for Q2 2019, filed 14 Aug 2019.